主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
单位:300162天津,武装警察部队后勤学院附属医院胸心血管外科
英文关键词:
【摘要】目的 观察缺氧诱导因子1α(HIF-1α)在非小细胞肺癌组织中的表达及其与患者临床预后的关系。方法 选取2015年1月至2017年1月于武装警察部队后勤学院附属医院首诊新发非小细胞肺癌患者120例。使用免疫组织化学法测定患者初诊肺活检组织中HIF-1α蛋白表达水平,并收集患者1年随访的短期预后情况,分析HIF-1α表达对转移/复发以及死亡的影响。结果 HIF-1α阳性患者中血管内皮生长因子(VEGF)和VEGF受体2(VEGFR2)阳性者比例均高于HIF-1α阴性患者[77.3%(68/88)比65.6%(21/32)、75.0%(66/88)比62.5%(20/32)],差异均有统计学意义(均P<0.05)。随访1年间共有17例患者转移/复发,HIF-1α阳性患者的转移/复发率高于HIF-1α阴性患者[17.0%(15/88)比6.2%(2/32)],差异有统计学意义(P<0.05);有6例患者死亡,其中4例HIF-1α阳性,2例HIF-1α阴性。Logistic回归分析结果显示,HIF-1α阳性以及VEGF和VEGFR2阳性均为首诊新发非小细胞肺癌患者转移/复发、死亡以及合计不良预后的危险因素,比值比均大于1,均P<0.05。结论 HIF-1α阳性以及VEGF和VEGFR2阳性均为非小细胞癌转移/复发、死亡以及合计不良预后的危险因素。
【Abstract】Objective To investigate the expression of hypoxia inducible factor-1α(HIF-1α) in non-small cell lung cancer and the impact on prognosis. Methods From January 2015 to January 2017, 120 patients with newly diagnosed non-small cell lung cancer in the Affiliated Hospital of Logistics College of Chinese People′s Armed Police Forces were enrolled. Expression of HIF-1α in lung biopsy tissue was tested by immunohistochemistry. Prognosis of patients was observed in 1 year after discharge. The relation between HIF-1α expression and metastasis/recurrence or death was analyzed. Results Positive rates of vascular endothelial growth factor(VEGF) and VEGF receptor 2(VEGFR2) in HIF-1α positive patients were significantly higher than those in HIF-1α negative patients[77.3%(68/88) vs 65.6%(21/32), 75.0%(66/88) vs 62.5%(20/32)](P<0.05). During 1-year follow-up, 17 patients had metastasis or recurrence; the rate of metastasis/recurrence in HIF-1α positive patients was significantly higher than that in HIF-1α negative patients[17.0%(15/88) vs 6.2%(2/32)](P<0.05). There were 6 deaths, including 4 cases of HIF-1α positive and 2 cases of HIF-1α negative. Logistic regression analysis suggested that HIF-1α, VEGF and VEGFR2 positive expression were risk factors of metastasis/recurrence and death in non-small cell lung cancer patients(odds ratio>1, P<0.05). Conclusion HIF-1α, VEGF and VEGFR2 positive expression are risk factors of metastasis, recurrence and death in non-small cell lung cancer atients.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。